Werner, Rudolf A.
Pienta, Kenneth J.
Pomper, Martin G.
Gorin, Michael A.
Rowe, Steven P.
Lodge, Martin A.
Bundschuh, Ralph A.
Article History
First Online: 12 December 2019
Compliance with Ethical Standards
:
: MGP is a co-inventor on a US patent covering 18F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. SPR is a consultant to Progenics Pharmaceuticals, the licensee of 18F-DCFPyL. MAG has served as a consultant to Progenics Pharmaceuticals. SPR, MAG, KJP, and MGP receive research funding from Progenics Pharmaceuticals. No other potential conflicts of interest relevant to this article exist.